Who should be considered for treatment with exenatide, according to - ProProfs Discuss
Advertisement

Who should be considered for treatment with exenatide, according to NICE guidelines?

Asked by Aaliyah, Last updated: May 14, 2021

+ Answer
Request
Question menu
Vote up Vote down

1 Answer

John Smith

John Smith

John Smith
John Smith

Answered Sep 08, 2016

Patients who are unable to control glycaemic control despite maximal doses of metformin and/or sulphonylureas-2. patients who have a bmi >35kg/m^2-quoted from nice guidelines cg66 update:exenatide: glp-1 mimeticsr44 exenatide is not recommended for routine use in type 2 diabetes.r45 consider exenatide as an option only if all the following apply for the individual: a body mass index over 35.0 kg/m2 in those of european descent, with appropriate adjustment in tailoring this advice for other ethnic groups specific problems of a psychological, biochemical or physical nature arising from high body weight inadequate blood glucose control (hba1c 7.5 %) with conventional oral agents after a trial of metformin and sulfonylurea other high-cost medication, such as a thiazolidinedione or insulin injection therapy, would otherwise be started.r46 continue exenatide therapy only if a beneficial metabolic response (at least 1.0 % hba1c reduction in 6 months and a weight loss of at least 5% at 1 year) occurs and is maintained.note: use with thiazolidinediones is not yet recommended in the uk but the fda has approved it in the usa
upvote downvote
Reply 

Advertisement
Advertisement
Search for Google images Google Image Icon
Select a recommended image
Upload from your computer Loader
Image Preview
Search for Google images Google Image Icon
Select a recommended image
Upload from your computer Loader
Image Preview
Search for Google images Google Image Icon
Select a recommended image
Upload from your computer Loader

Email Sent
We have sent an email to your address "" with instructions to reset your password.